RecallRadar

FDA Device recall Z-1813-2018

Infinity Acute Care System (lACS) Monitoring Solution

On 2018-05-23 the FDA classified a Class II recall of Infinity Acute Care System (lACS) Monitoring Solution by Draegar Medical Systems, citing software anomaly resulting in the loss of patient settings and stored patient data.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1813-2018
ClassificationClass II
Statusterminated
Initiated2018-03-28
Published2018-05-23
Last updated2026-09-13 11:54 UTC
CompanyDraegar Medical Systems
DistributionUS

Product

Infinity Acute Care System (lACS) Monitoring Solution; Catalog Numbers:MS20401, MS20724, MS22956, MS25510, MS25520, MS25643, MS26196, MS26372, MS31818; UDI Information: 4049098054454, 4049098054447, 4049098054409, 4049098009799, 4049098009751. Multi-parameter, physiologic patient monitoring of adult, pediatric and neonatal patients in environments where patient care is provided by trained healthcare professionals. The lACS obtains the physiologic, multi-parameter data from the connection to the M540 monitor and optional medical devices and displays. The transfer of this data is accomplished by the Infinity network. The M540 is intended to monitor one patient at a time.

Reason

Software anomaly resulting in the loss of patient settings and stored patient data.

Identifiers

code_info
Catalog Numbers:MS20401, MS20724, MS22956, MS25510, MS25520, MS25643, MS26196, MS26372, MS31818 UDI Information: 404…Catalog Numbers:MS20401, MS20724, MS22956, MS25510, MS25520, MS25643, MS26196, MS26372, MS31818 UDI Information: 4049098054454, 4049098054447, 4049098054409, 4049098009799, 4049098009751.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1813-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.